Analyst consensus rating
Turn Therapeutics Analyst Rating: Strong Buy
TTRX is rated Strong Buy by 1 analysts with a $26.00 target. As of 2026-08-27.
Direct answer
Turn Therapeutics's consensus rating is Strong Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $26.00.
Forecast evidence checked August 27, 2026.
Get free Turn Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.63
- Average price target
- $26.00
- High price target
- $26.00
- Low price target
- $26.00
- Low target gap
- +170%
- Target upside
- +170%
- High target gap
- +170%
- Target range width
- 0%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Turn Therapeutics?
Turn Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $26.00.
How far are Turn Therapeutics's low and high targets from the recorded price?
The low target implies +170%, while the high target implies +170%.
How many analysts are included in Turn Therapeutics's consensus?
The verified consensus includes 1 analysts.
How is Turn Therapeutics's target upside or downside calculated?
The average target of $26.00 is divided by the recorded price of $9.63, then one is subtracted to produce +170%. This does not guarantee a future return.
When was Turn Therapeutics's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.